Sectra MicroDose Mammography receives Product Quality Leadership Award
Sectra has been recognized by Frost & Sullivan for its unique photon counting mammography system, Sectra MicroDose, with the Product Quality Leadership, Women's Health Imaging Europe 2010 award.
The award is based on evaluations in several areas including product performance, reliability and design.
Frost & Sullivan summarizes the industry challenges as "…the success of mammography vendors lies in their ability to develop new innovative products and enhance existing product line to not only meet patient requirements of comfort and safety but also regulatory requirements such as low dose radiation exposure without having to compromise on image quality."
“We head for improved customer productivity gains and clinical outcomes in our continuous development of existing products as well as in our research aimed at further improving breast cancer detection – for example through 3D imaging and spectral mammography." says Jesper Söderqvist, President of Sectra's mammography operations.
About Sectra MicroDose Mammography
Mammography screening is the best method for early breast cancer detection. Breast tissue is sensitive to radiation, and it is therefore crucial that the dose is as low as possible. This is especially important in mammography screening, which involves examination of a large number of healthy women. With superior image quality, Sectra’s mammography system, Sectra MicroDose Mammography[1], generates by far the lowest dose of radiation of all of the systems offered on the market. Sectra MicroDose Mammography is based on photon counting technology. MicroDose Mammography has already been installed at numerous hospitals and clinics in 17 European countries, as well as in Australia, New Zealand and Japan.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com/.
[1] Pending FDA approval
For further information, please contact:
Dr. Torbjörn Kronander, President, Sectra Imtec AB, +46 705 23 52 27
Dr. Jan-Olof Brüer, CEO and President, Sectra AB, +46 13 23 52 09
About Sectra’s medical operations
Sectra develops and sells IT-systems and products for radiology, mammography and orthopaedic departments. More than 1,100 hospitals worldwide use the system daily, together performing over 52 million radiology examinations annually. This makes Sectra one of the world leading companies within systems for handling digital radiology images (PACS). In Scandinavia, Sectra is the market leader with more than 50% of all film-free installations. Outside Scandinavia, Sectra’s system is installed at customers in North America and most major countries in Europe and the Far East.
About the Sectra Group
Sectra successfully develops and sells cutting-edge products in the expansive niche segments of medical systems and secure communication systems. The company was founded in 1978 and has its roots in the Linköping Institute of Technology in Sweden. Today, Sectra has offices in twelve countries and operates through partners worldwide. Sales in the 2009/2010 fiscal year totaled SEK 848 million. The Sectra share is quoted on the NASDAQ OMX Stockholm AB exchange. For more information, visit http://www.sectra.com/.
Tags:
